Accredited continuing education (CE) can always include information about investigational research and therapies, so long as that content meets the expectations of the ACCME’s CME Clinical Content Validation Policy. In an emergent crisis like this, accredited CE is uniquely positioned to provide learners context and information to help them evaluate emerging evidence.
There is no intent to shortcut content validation. During this crisis, it is critical that accredited providers and their faculty ensure that accredited CE addresses the content validity of clinical recommendations related to COVID-19. The Planning Form for Expedited Accredited Activities removes the requirement of disclosure of relevant financial relationships and resolution of personal conflicts of interest because, currently, there are no FDA-approved vaccines or treatments for COVID-19. Hence, there is no possibility of a relevant financial relationship that would create a conflict of interest.